Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoneridge (SRI) Cash & Equivalents (2016 - 2025)

Stoneridge's Cash & Equivalents history spans 16 years, with the latest figure at $66.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 7.77% year-over-year to $66.3 million; the TTM value through Dec 2025 reached $66.3 million, down 7.77%, while the annual FY2025 figure was $66.3 million, 7.77% down from the prior year.
  • Cash & Equivalents reached $66.3 million in Q4 2025 per SRI's latest filing, up from $54.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $85.5 million in Q4 2021 to a low of $32.3 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $51.7 million, with a median of $49.9 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: crashed 35.94% in 2022, then surged 75.88% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $85.5 million in 2021, then crashed by 35.94% to $54.8 million in 2022, then decreased by 25.47% to $40.8 million in 2023, then soared by 75.88% to $71.8 million in 2024, then fell by 7.77% to $66.3 million in 2025.
  • Per Business Quant, the three most recent readings for SRI's Cash & Equivalents are $66.3 million (Q4 2025), $54.0 million (Q3 2025), and $49.8 million (Q2 2025).